Author:
Zhang Jie,Wang Chen,He Qian-Yun,Mao Dong-Liang,Huang Lei,Wang Mei,Zhang Jun
Abstract
Abstract
Purpose
To investigate the ability to self-manage symptoms in patients with chemotherapy-induced HFS and to provide guidance for developing a self-management plan that meets patient needs.
methods
From July 2022 to July 2023, 22 patients with chemotherapy-induced HFS were selected by objective sampling in the oncology department of a tertiary hospital in Shanghai. A semi-structured in-depth face-to-face interview was used to collect the case data, and the content analysis method was used for analysis, and the topic was refined.
Results
Twenty-two patients were interviewed. Three themes and six sub-themes emerged from the analytical interviews: the first theme was "Patient attitude and emotional response to symptoms," which consisted of patients gradually accepting the symptoms of HFS and adapting to some mild manifestations based on the following responses, showing different emotional responses to HFS, symptoms that affected their daily life. The patient feels guilty for his family and suffers from a self-image disorder. The second theme is "symptom experience," with symptoms that vary from patient to patient and have a different impact on the individual's life, including pain and itching. The third theme is "coping strategies," which include patients feeling the effects of limited social interaction and family relationships. The fourth topic, "Expectations for the future," includes gaining relevant knowledge through the website, doctors, and patients, changing habits, demonstrating symptom improvement, and meeting/exceeding the expectations of healthcare providers.
Conclusions
Healthcare providers should provide more education and emotional support to patients with chemotherapy-induced HFS to enable symptom management, elicit positive experiences.
Publisher
Research Square Platform LLC
Reference59 articles.
1. Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer;Bun S;Support Care Cancer,2018
2. Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized Clinical Trial;Yap YS;JAMA Oncol,2017
3. Variants of carboxylesterase 1 have no impact on capecitabine pharmacokinetics and toxicity in capecitabine plus oxaliplatin treated-colorectal cancer patients;Matsumoto N;Cancer Chemother Pharmacol,2020
4. Patient reported barriers and facilitators to using a self-management booklet for hip and knee osteoarthritis in primary care: results of a qualitative interview study;Nienke Cuperus AJS;BMC Fam Pract,2013
5. Ramasubbu MK, et al. Chemotherapy-induced hand foot syndrome: comparative efficacy and safety of pharmacological prophylaxis - systematic review and Bayesian network meta-analysis. BMJ Support Palliat Care; 2022.